NutriStem MSC Culture System

This event has concluded. We will be exhibiting and presenting at the Cell Culture Medium Symposium at Shonan, held at Shonan Ai Park on September 13, 2024 (Friday). At our booth, we will introduce Sartorius's wide range of media, raw materials, and services that meet the needs of cell culture. *You can view the program in the "Related Materials." [Event Overview] Date and Time: September 13, 2024 (Friday) 10:00 AM - 5:45 PM Location: Shonan Ai Park or online *Pre-registration required [Our Seminar] Title: Recombumin | Enabling safe and robust manufacturing across various modalities with recombinant human albumin Speaker: Shiori Akiyama (Sales Development Specialist - Cell Lines, Media, Various Tests) Seminar Time: 3:40 PM - 4:10 PM Overview: This seminar will focus on Recombumin, a recombinant human albumin that improves cell viability after cryopreservation and has an effect on suppressing the aggregation of cells and vectors.

Expectations for regenerative medicine using stem cells such as mesenchymal stem cells (MSC) and induced pluripotent stem cells (iPSC) are rising, but for industrialization, there is a need for technology to produce high-quality cells in large quantities and in a stable manner. In this seminar, we will introduce xenofree stem cell culture media that do not contain components derived from animals other than humans, as well as examples of 3D culture using our microcarriers, bioreactors, and experimental design software. We will also present HEK media used for immune cell culture media and lentivirus production as products for cell therapy, such as CAR-T. 【Seminar Overview】 ▪ Date: October 12 (Thursday) from 3:00 PM (approximately 30 minutes) ▪ Format: Webinar recorded broadcast [Japanese, Free] If you are unable to attend on the day, please register first. Later, we will send you a link to download the recorded video and related product materials. *We apologize, but participation from other companies in the same industry, as well as email addresses not associated with your organization, is not permitted. Thank you for your understanding.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Cellular immunotherapy has scientifically proven the efficacy of CAR-T cells in the treatment of blood cancers, and development is progressing globally. This has heightened interest in the scientific and medical communities and serves as a driving force to develop more effective and cost-efficient cellular immunotherapies. Therefore, the development of high-quality auxiliary materials such as culture media for cultivating these immune cells is crucial. To meet such needs, our company has developed the serum-free 4Cell Nutri-T Medium. Method of delivery: Webinar recorded broadcast (with Japanese subtitles, free of charge) *We sincerely apologize, but participation from email addresses other than those of your company or organization is not permitted. Thank you for your understanding.